<SEC-DOCUMENT>0001415889-24-019797.txt : 20240718
<SEC-HEADER>0001415889-24-019797.hdr.sgml : 20240718
<ACCEPTANCE-DATETIME>20240718200514
ACCESSION NUMBER: 0001415889-24-019797
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240718
FILED AS OF DATE: 20240718
DATE AS OF CHANGE: 20240718
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GC Corp.
CENTRAL INDEX KEY: 0001931382
ORGANIZATION NAME:
STATE OF INCORPORATION: M5
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-42179
FILM NUMBER: 241125805
BUSINESS ADDRESS:
STREET 1: 107 IHYEON-RO,30BEON-GIL
STREET 2: GILHEUNG-GU, YONGIN-SI
CITY: GYEONGGI-DO
STATE: M5
ZIP: 16924
BUSINESS PHONE: 82-31-260-9300
MAIL ADDRESS:
STREET 1: 107 IHYEON-RO,30BEON-GIL
STREET 2: GILHEUNG-GU, YONGIN-SI
CITY: GYEONGGI-DO
STATE: M5
ZIP: 16924
FORMER NAME:
FORMER CONFORMED NAME: Green Cross Holdings Corp
DATE OF NAME CHANGE: 20220526
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GC Cell Corp
CENTRAL INDEX KEY: 0001931891
ORGANIZATION NAME:
STATE OF INCORPORATION: M5
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-42179
FILM NUMBER: 241125804
BUSINESS ADDRESS:
STREET 1: 107 IHYEON-RO, 30BEON-GIL
STREET 2: GILHEUNG-GU, YONGIN-SI
CITY: GYEONGGI-DO
STATE: M5
ZIP: 16924
BUSINESS PHONE: 82-31-260-9300
MAIL ADDRESS:
STREET 1: 107 IHYEON-RO, 30BEON-GIL
STREET 2: GILHEUNG-GU, YONGIN-SI
CITY: GYEONGGI-DO
STATE: M5
ZIP: 16924
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Artiva Biotherapeutics, Inc.
CENTRAL INDEX KEY: 0001817241
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 863614316
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5505 MOREHOUSE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: (858) 267-4467
MAIL ADDRESS:
STREET 1: 5505 MOREHOUSE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>form3-07192024_120709.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>
<schemaVersion>X0206</schemaVersion>
<documentType>3</documentType>
<periodOfReport>2024-07-18</periodOfReport>
<noSecuritiesOwned>0</noSecuritiesOwned>
<issuer>
<issuerCik>0001817241</issuerCik>
<issuerName>Artiva Biotherapeutics, Inc.</issuerName>
<issuerTradingSymbol>ARTV</issuerTradingSymbol>
</issuer>
<reportingOwner>
<reportingOwnerId>
<rptOwnerCik>0001931382</rptOwnerCik>
<rptOwnerName>GC Corp.</rptOwnerName>
</reportingOwnerId>
<reportingOwnerAddress>
<rptOwnerStreet1>107 IHYEON-RO,30BEON-GIL</rptOwnerStreet1>
<rptOwnerStreet2>GILHEUNG-GU, YONGIN-SI</rptOwnerStreet2>
<rptOwnerCity>GYEONGGI-DO</rptOwnerCity>
<rptOwnerState>M5</rptOwnerState>
<rptOwnerZipCode>16924</rptOwnerZipCode>
<rptOwnerStateDescription>KOREA, REPUBLIC OF</rptOwnerStateDescription>
</reportingOwnerAddress>
<reportingOwnerRelationship>
<isDirector>false</isDirector>
<isOfficer>false</isOfficer>
<isTenPercentOwner>true</isTenPercentOwner>
<isOther>false</isOther>
<officerTitle></officerTitle>
<otherText></otherText>
</reportingOwnerRelationship>
</reportingOwner>
<reportingOwner>
<reportingOwnerId>
<rptOwnerCik>0001931891</rptOwnerCik>
<rptOwnerName>GC Cell Corp</rptOwnerName>
</reportingOwnerId>
<reportingOwnerAddress>
<rptOwnerStreet1>107 IHYEON-RO, 30BEON-GIL</rptOwnerStreet1>
<rptOwnerStreet2>GIHEUNG-GU, YONGIN-S</rptOwnerStreet2>
<rptOwnerCity>GYEONGGI-DO,</rptOwnerCity>
<rptOwnerState>M5</rptOwnerState>
<rptOwnerZipCode>16924</rptOwnerZipCode>
<rptOwnerStateDescription>KOREA, REPUBLIC OF</rptOwnerStateDescription>
</reportingOwnerAddress>
<reportingOwnerRelationship>
<isDirector>0</isDirector>
<isOfficer>0</isOfficer>
<isTenPercentOwner>1</isTenPercentOwner>
<isOther>0</isOther>
<officerTitle></officerTitle>
<otherText></otherText>
</reportingOwnerRelationship>
</reportingOwner>
<nonDerivativeTable>
<nonDerivativeHolding>
<securityTitle>
<value>Common Stock</value>
</securityTitle>
<postTransactionAmounts>
<sharesOwnedFollowingTransaction>
<value>348837</value>
</sharesOwnedFollowingTransaction>
</postTransactionAmounts>
<ownershipNature>
<directOrIndirectOwnership>
<value>D</value>
<footnoteId id="F1"/>
</directOrIndirectOwnership>
<natureOfOwnership>
<value></value>
</natureOfOwnership>
</ownershipNature>
</nonDerivativeHolding>
<nonDerivativeHolding>
<securityTitle>
<value>Common Stock</value>
</securityTitle>
<postTransactionAmounts>
<sharesOwnedFollowingTransaction>
<value>232558</value>
</sharesOwnedFollowingTransaction>
</postTransactionAmounts>
<ownershipNature>
<directOrIndirectOwnership>
<value>I</value>
</directOrIndirectOwnership>
<natureOfOwnership>
<value>By GC Cell Corporation</value>
<footnoteId id="F2"/>
</natureOfOwnership>
</ownershipNature>
</nonDerivativeHolding>
</nonDerivativeTable>
<derivativeTable>
<derivativeHolding>
<securityTitle>
<value>Series A Preferred Stock</value>
</securityTitle>
<conversionOrExercisePrice>
<footnoteId id="F3"/>
</conversionOrExercisePrice>
<exerciseDate>
<footnoteId id="F3"/>
</exerciseDate>
<expirationDate>
<footnoteId id="F3"/>
</expirationDate>
<underlyingSecurity>
<underlyingSecurityTitle>
<value>Common Stock</value>
</underlyingSecurityTitle>
<underlyingSecurityShares>
<value>667185</value>
</underlyingSecurityShares>
</underlyingSecurity>
<ownershipNature>
<directOrIndirectOwnership>
<value>D</value>
<footnoteId id="F1"/>
</directOrIndirectOwnership>
<natureOfOwnership>
<value></value>
</natureOfOwnership>
</ownershipNature>
</derivativeHolding>
<derivativeHolding>
<securityTitle>
<value>Series B Preferred Stock</value>
</securityTitle>
<conversionOrExercisePrice>
<footnoteId id="F3"/>
</conversionOrExercisePrice>
<exerciseDate>
<footnoteId id="F3"/>
</exerciseDate>
<expirationDate>
<footnoteId id="F3"/>
</expirationDate>
<underlyingSecurity>
<underlyingSecurityTitle>
<value>Common Stock</value>
</underlyingSecurityTitle>
<underlyingSecurityShares>
<value>330095</value>
</underlyingSecurityShares>
</underlyingSecurity>
<ownershipNature>
<directOrIndirectOwnership>
<value>D</value>
<footnoteId id="F1"/>
</directOrIndirectOwnership>
<natureOfOwnership>
<value></value>
</natureOfOwnership>
</ownershipNature>
</derivativeHolding>
<derivativeHolding>
<securityTitle>
<value>Series A Preferred Stock</value>
</securityTitle>
<conversionOrExercisePrice>
<footnoteId id="F3"/>
</conversionOrExercisePrice>
<exerciseDate>
<footnoteId id="F3"/>
</exerciseDate>
<expirationDate>
<footnoteId id="F3"/>
</expirationDate>
<underlyingSecurity>
<underlyingSecurityTitle>
<value>Common Stock</value>
</underlyingSecurityTitle>
<underlyingSecurityShares>
<value>292791</value>
</underlyingSecurityShares>
</underlyingSecurity>
<ownershipNature>
<directOrIndirectOwnership>
<value>I</value>
</directOrIndirectOwnership>
<natureOfOwnership>
<value>By GC Cell Corporation</value>
<footnoteId id="F2"/>
</natureOfOwnership>
</ownershipNature>
</derivativeHolding>
<derivativeHolding>
<securityTitle>
<value>Series B Preferred Stock</value>
</securityTitle>
<conversionOrExercisePrice>
<footnoteId id="F3"/>
</conversionOrExercisePrice>
<exerciseDate>
<footnoteId id="F3"/>
</exerciseDate>
<expirationDate>
<footnoteId id="F3"/>
</expirationDate>
<underlyingSecurity>
<underlyingSecurityTitle>
<value>Common Stock</value>
</underlyingSecurityTitle>
<underlyingSecurityShares>
<value>62181</value>
</underlyingSecurityShares>
</underlyingSecurity>
<ownershipNature>
<directOrIndirectOwnership>
<value>I</value>
</directOrIndirectOwnership>
<natureOfOwnership>
<value>By GC Cell Corporation</value>
<footnoteId id="F2"/>
</natureOfOwnership>
</ownershipNature>
</derivativeHolding>
</derivativeTable>
<footnotes>
<footnote id="F1">GC Corp., a public Korean holdings company, is ultimately controlled by its board of directors, consisting of Mr. Yong-Jun Huh, Huh II-Sup, Park Yong-Tae and Kim Seok-Hwa. Each of these individual directors of GC Corp. may be deemed to share voting and investment power over the shares held by GC Corp. and each disclaims beneficial ownership of all shares held by CG Corp., except to the extent of any pecuniary interest therein.</footnote>
<footnote id="F2">The shares are held directly by GC Cell Corporation. GC Corp., a public Korean holdings company, is the parent company of GC Cell Corporation and is ultimately controlled by its board of directors, consisting of Mr. Yong-Jun Huh, Huh II-Sup, Park Yong-Tae and Kim Seok-Hwa. Each of these individual directors of GC Corp. may be deemed to share voting and investment power over the shares held by GC Corp. and GC Cell Corporation and each disclaims beneficial ownership of all shares held by such entities, except to the extent of any pecuniary interest therein.</footnote>
<footnote id="F3">Each share of Series A Preferred Stock and Series B Preferred Stock (collectively, the "Preferred Stock") is convertible into shares of Common Stock of the Issuer on a one-for-one basis without payment of further consideration. Upon the closing of the Issuer's initial public offering, the Preferred Stock will
convert into the number of shares of Common Stock of the Issuer shown in column 3. The Preferred Stock has no expiration date.</footnote>
</footnotes>
<ownerSignature>
<signatureName>GC Corp By: /s/ Yong-Jun Huh, Chief Executive Officer</signatureName>
<signatureDate>2024-07-18</signatureDate>
</ownerSignature>
<ownerSignature>
<signatureName>GC Cell Corporation By: /s/ James Park, Chief Executive Officer</signatureName>
<signatureDate>2024-07-18</signatureDate>
</ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>